Isoform-specific functions of c-abl: Type I is necessary for differentiation, and type IV is inhibitory to apoptosis

Cell Growth and Differentiation

Volumn 7, Issue 9, 1996, Pages 1141-1148

  Daniel, Rene ^a   Wong, Peter M C ^a   Chung, Siu Wah ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN LIGHT CHAIN; LIPOPOLYSACCHARIDE; ONCOPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA CLEAVAGE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GROWTH REGULATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; DNA FRAGMENTATION; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; LIPOPOLYSACCHARIDES; MICE; MITOGENS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-ABL; RNA, MESSENGER;

ANIMALIA;

EID: 0029823748     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wang, J. Y. J. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev., 3: 35-43, 1993.
2. Van Etten, R. A., Jackson, P., and Baltimore, D. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell, 58: 669-678, 1989.
3. Kipreos, E. T., and Wang, J. Y. J. Differential phosphorylation of c-abl in cell cycle determined by cdc2 kinase and phosphatase activity. Science (Washington DC), 248: 217-220, 1990.
4. Kipreos, E. T., and Wang, J. Y. J. Cell cycle-regulated binding of c-abl tyrosine kinase to DNA. Science (Washington DC), 256: 382-385, 1992.
5. McWhirter, J. R., and Wang, J. Y. J. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol., 11: 1553-1565, 1991.
6. Franz, W. M., Berger, P., and Wang, J. Y. J. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J., 8: 137-147, 1989.
7. Ren, R., Ye, Z. S., and Baltimore, D. ABL protein-tyrosine kinase selects the Crk adaptor as a substrate using SH3-binding sites. Genes Dev., 8: 783-795, 1994.
8. Welch, P. J., and Wang, J. Y. J. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-abl tyrosine kinase in the cell cycle. Cell, 75: 779-790, 1993.
9. Baskaran, R., Dahmus, M. E., and Wang, J. Y. J. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA, 90: 11167-11171, 1993.
10. Feller, S. M., Knudsen, B., and Manafuza, H. C-Abl kinase regulates the protein activity of c-Crk. EMBO J., 13: 2341-2351, 1994.
11. Schwartzberg, P. L., Stall, A. M., Hardin, J. D., Bowdish, K. S., Humaran, T., Boast, S., Harbison, M. L., Robertson, E. J., and Goff, S. P. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65: 1165-1175, 1991.
12. Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., and Mulligan, R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell, 65: 1153-1163, 1991.
13. Ben-Neriah, Y., Bernards, A., Paskind, M., Daley, D. Q., and Baltimore, D. Alternative 5′-exons in c-abl mRNA. Cell, 44: 577-586, 1986.
14. Bernards, A., Paskind, M., and Baltimore, D. Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing. Oncogene, 2: 297-304, 1988.
15. Renshaw, M. W., Capozza, M. A., and Wang, J. Y. J. Differential expression of type-specific c-abl mRNA in mouse tissues and cell lines. Mol. Cell. Biol., 9: 4547-4551, 1988.
16. Muller, R., Slamon, D. J., Tremblay, J. M., Cline, M. J., and Verma, I. Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (Lond.), 299: 640-644, 1982.
17. Oppi, C., Shore, S. K., and Reddy, E. P. Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation. Proc. Natl. Acad. Sci. USA, 84: 8200-8204, 1987.
18. Williams, G. T., Smith, C. A., Spooncer, E., Dexter, M. T., and Taylor, D. R. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature (Lond.), 343: 76-79, 1990.
19. Caracciolo, D., Valtieri, M., Venturelli, D., Peschle, C., Gewirtz, A. M., and Calabretta, B. Lineage-specific requirement of c-abl function in normal hematopoiesis. Science (Washington DC), 245: 1107-1110, 1989.
20. Perry, R. P., and Kelley, D. E. Immunoglobulin messenger RNAs in murine cell lines that have characteristics of immature B lymphocytes. Cell, 18: 1333-1339, 1979.
21. Aloni-Grinstein, R., Zan-Bar, I., Alboum, I., Goldfinger, N., and Rotter, V. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene, 8: 3297-3305, 1993.
22. Vaerman, J. L., Lammineur, C., Moureau, P., Lewalle, P., Deldime, F., Blumenfeld, M., and Martial, P. BCR-ABL antisense oligodeoxynucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism. Blood, 86: 3891-3896, 1995.
23. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
24. Daniel, R., Cai, Y., Wong, P. M. C., and Chung, S-W. Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences. Oncogene, 10: 1607-1614, 1995.